Signaling Pathways - MARK1 - metalloprotease - Insulin and Insulin-like Receptors - M3 Receptors
清除全部
-
B4790 Phosphoramidon Disodium Salt中文名: 磷酰二肽，膦酰二肽钠Target: metalloproteaseSummary: 金属蛋白酶抑制剂 -
B1607 Otilonium Bromide中文名: 奥替溴铵Target: M3 ReceptorsSummary: AChR抑制剂 -
B1600 Darifenacin HBr中文名: 氢溴酸达非那新Target: M3 ReceptorsSummary: 选择性M3毒蕈碱受体拮抗剂 -
B1614 Solifenacin succinate中文名: 琥珀酸索非那新Target: M3 ReceptorsSummary: 毒蕈碱受体拮抗剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A8369 Atropine sulfate monohydrate中文名: 硫酸阿托品一水合物Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 ReceptorsSummary: MAChRs拮抗剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂